BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23233409)

  • 1. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends in survival from cancer of unknown primary: small steps forward.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2014 Jun; 14():439. PubMed ID: 24929562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in cancer of unknown primary site: population-based analysis by site and histology.
    Hemminki K; Bevier M; Hemminki A; Sundquist J
    Ann Oncol; 2012 Jul; 23(7):1854-63. PubMed ID: 22115926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic sites and survival in lung cancer.
    Riihimäki M; Hemminki A; Fallah M; Thomsen H; Sundquist K; Sundquist J; Hemminki K
    Lung Cancer; 2014 Oct; 86(1):78-84. PubMed ID: 25130083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
    Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
    Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of metastases in neuroendocrine tumors.
    Riihimäki M; Hemminki A; Sundquist K; Sundquist J; Hemminki K
    Int J Cancer; 2016 Dec; 139(12):2679-2686. PubMed ID: 27553864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
    Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
    Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
    Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
    Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
    Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.